×
About 205,168 results

ALLMedicine™ Heart Failure Center

Research & Reviews  96,207 results

Extracellular Superoxide Dismutase Is Associated With Left Ventricular Geometry and Hea...
https://doi.org/10.1161/JAHA.120.016862
Journal of the American Heart Association; Li X, Lin Y et. al.

Aug 4th, 2020 - Background Extracellular superoxide dismutase (Ec-SOD) is a major scavenger of reactive oxygen species. However, its relationships with abnormal left ventricular (LV) geometry patterns and heart failure (HF) are still unknown in patients with card...

Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natr...
https://doi.org/10.1161/JAHA.119.015738
Journal of the American Heart Association; Vaishnav J, Chasler JE et. al.

Aug 4th, 2020 - Background Heart failure with preserved ejection fraction (HFpEF) constitutes half of hospitalized heart failure cases and is commonly associated with obesity. The role of natriuretic peptide levels in hospitalized obese patients with HFpEF, howev...

Elevated Heart Rate and Survival in Children With Dilated Cardiomyopathy: A Multicenter...
https://doi.org/10.1161/JAHA.119.015916
Journal of the American Heart Association; Rossano JW, Kantor PF et. al.

Aug 4th, 2020 - Background In adults with heart failure, elevated heart rate is associated with lower survival. We determined whether an elevated heart rate was associated with an increased risk of death or heart transplant in children with dilated cardiomyopathy...

Clinical Implications of Hepatic Hemodynamic Evaluation by Abdominal Ultrasonographic I...
https://doi.org/10.1161/JAHA.120.016689
Journal of the American Heart Association; Yoshihisa A, Ishibashi S et. al.

Aug 4th, 2020 - Background It has been reported that liver stiffness assessed by transient elastography are correlated with right atrial pressure, which is associated with worse outcome in patients with heart failure (HF). We aimed to clarify clinical implication...

Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Fa...
https://doi.org/10.1161/JAHA.119.016009
Journal of the American Heart Association; Wei FF, Xue R et. al.

Aug 4th, 2020 - Background Data on the association of systolic and diastolic blood pressure with the structure and function of failing hearts with preserved ejection fraction (EF) are sparse. Methods and Results This analysis included 935 patients with heart fail...

see more →

Guidelines  285 results

2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institut...
https://doi.org/10.1016/j.jtcvs.2019.12.001
The Journal of Thoracic and Cardiovascular Surgery; , Bonow RO et. al.

Jun 16th, 2020 - 2019 AATS/ACC/SCAI/STS expert consensus systems of care document: Operator and institutional recommendations and requirements for transcatheter mitral valve intervention: A joint report of the American Association for Thoracic Surgery, the America...

Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314099
European Heart Journal; Anker SD, Butler J et. al.

Jun 4th, 2020 - The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has important implications for the safety of participants in clinical trials and the research staff caring for them and, ...

Meeting News From ACC 2020
https://www.healio.com/cardiology/meeting-news/acc-meeting
Cardiology Today;

Apr 1st, 2020 - The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.

Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician
https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician
American Heart Association;

Mar 16th, 2020 - As the global impact of COVID-19 rises, the scientific community continues to evaluate the clinical impact and health care needs of patients with cardiovascular disease, who are at increased risk for serious complications with COVID-19. Together, ...

2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transpla...
https://doi.org/10.1016/j.jacc.2019.09.030
Journal of the American College of Cardiology; Yancy CW, Drazner MH et. al.

Feb 22nd, 2020 - 2020 ACC/HFSA/ISHLT Lifelong Learning Statement for Advanced Heart Failure and Transplant Cardiology Specialists: A Report of the ACC Competency Management Committee.|2020|Yancy CW,Drazner MH,Coffin ST,Cornwell W,Desai S,|

see more →

Drugs  2,427 results see all →

Clinicaltrials.gov  101,241 results

Extracellular Superoxide Dismutase Is Associated With Left Ventricular Geometry and Hea...
https://doi.org/10.1161/JAHA.120.016862
Journal of the American Heart Association; Li X, Lin Y et. al.

Aug 4th, 2020 - Background Extracellular superoxide dismutase (Ec-SOD) is a major scavenger of reactive oxygen species. However, its relationships with abnormal left ventricular (LV) geometry patterns and heart failure (HF) are still unknown in patients with card...

Highest Obesity Category Associated With Largest Decrease in N-Terminal Pro-B-Type Natr...
https://doi.org/10.1161/JAHA.119.015738
Journal of the American Heart Association; Vaishnav J, Chasler JE et. al.

Aug 4th, 2020 - Background Heart failure with preserved ejection fraction (HFpEF) constitutes half of hospitalized heart failure cases and is commonly associated with obesity. The role of natriuretic peptide levels in hospitalized obese patients with HFpEF, howev...

Elevated Heart Rate and Survival in Children With Dilated Cardiomyopathy: A Multicenter...
https://doi.org/10.1161/JAHA.119.015916
Journal of the American Heart Association; Rossano JW, Kantor PF et. al.

Aug 4th, 2020 - Background In adults with heart failure, elevated heart rate is associated with lower survival. We determined whether an elevated heart rate was associated with an increased risk of death or heart transplant in children with dilated cardiomyopathy...

Clinical Implications of Hepatic Hemodynamic Evaluation by Abdominal Ultrasonographic I...
https://doi.org/10.1161/JAHA.120.016689
Journal of the American Heart Association; Yoshihisa A, Ishibashi S et. al.

Aug 4th, 2020 - Background It has been reported that liver stiffness assessed by transient elastography are correlated with right atrial pressure, which is associated with worse outcome in patients with heart failure (HF). We aimed to clarify clinical implication...

Associations of Left Ventricular Structure and Function With Blood Pressure in Heart Fa...
https://doi.org/10.1161/JAHA.119.016009
Journal of the American Heart Association; Wei FF, Xue R et. al.

Aug 4th, 2020 - Background Data on the association of systolic and diastolic blood pressure with the structure and function of failing hearts with preserved ejection fraction (EF) are sparse. Methods and Results This analysis included 935 patients with heart fail...

see more →

News  4,845 results

Roche's combo therapy for advanced breast cancer gets U.S. FDA approval
https://www.reuters.com/article/us-roche-hldg-fda/roches-combo-therapy-for-advanced-breast-cancer-gets-u-s-fda-approval-idUSKBN240297

Jun 29th, 2020 - (Reuters) - The U.S. Food and Drug Administration on Monday approved Roche Holding AG’s combination therapy for a form of advanced breast cancer that has spread to other parts of the body. The therapy, Phesgo, was approved for patients with HER2-p...

FDA approves emergency use of Abiomed heart pump for COVID-19 patients
https://www.reuters.com/article/us-health-coronavirus-abiomed/fda-approves-emergency-use-of-abiomed-heart-pump-for-covid-19-patients-idUSKBN2382F3

Jun 1st, 2020 - (Reuters) - Abiomed Inc said on Monday the U.S. Food and Drug Administration has granted emergency use authorization for its temporary invasive heart pump to help patients suffering from COVID-19 related right heart failure. The device, Impella RP...

AstraZeneca diabetes drug gets U.S. nod to treat heart failure
https://www.reuters.com/article/us-astrazeneca-fda/astrazeneca-diabetes-drug-gets-u-s-nod-to-treat-heart-failure-idUSKBN22I0MM

May 6th, 2020 - (Reuters) - AstraZeneca’s diabetes drug Farxiga has become the first in its class to win U.S. approval as a treatment for heart failure, opening up a major new market opportunity outside of the medicine’s established field. FILE PHOTO: The company...

Meeting News From ACC 2020
https://www.healio.com/cardiology/meeting-news/acc-meeting
Cardiology Today;

Apr 1st, 2020 - The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.

VICTORIA: Vericiguat seen as novel success in tough-to-treat, high-risk heart failure
https://www.mdedge.com/cardiology/article/219745/heart-failure/victoria-vericiguat-seen-novel-success-tough-treat-high-risk/page/0/1?channel=39313

Mar 28th, 2020 - Such patients with advanced, late-stage disease are common as the latest therapies for heart failure prolong their survival, notes Lynne W. Stevenson, MD, Vanderbilt University, Nashville, Tennessee, also as an invited discussant after Armstrong’s.

see more →

Patient Education  163 results see all →